Skip to content
Screener

Houlihan Lokey HLI Financial and Valuation Advisory — Employee compensation and benefits

Other segment segments

Corporate Finance
$227.4M-3.6%
Financial Restructuring
$70.69M-20.8%
Financial Advisory Services
$48.53M+14.0%

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Employee compensation and benefits
$12.94M+19.9%
Lowe's Companies logo
LOWReportable Segment — Employee compensation and benefits
13.4%-0.1pp
Asset Entities logo
ASSTCorporate & Other — Employee compensation and benefits
$6.58M—
Asset Entities logo
ASSTMedical Device — Employee compensation and benefits
$5.18M—
Beneficient logo
BENFBen Custody — Employee compensation and benefits
$650K+121%
Beneficient logo
BENFBen Liquidity — Employee compensation and benefits
$464K+31.4%

Other financials

Income statement

See full
Revenue$635.6M-4.6%
Gross profit$230.7M+15.9%
Operating income$125.1M-11.3%
Net income$99.8M-18.1%
EPS (diluted)$1.48-16.4%

Balance sheet

See full
Cash & equivalents$1.2B+22.5%
Total debt$492.1M+12.3%
Total assets$4.3B+12.8%

Cash flow

See full
Operating cash flow$293.0M-18.2%
CapEx$6.3M-56.8%
Free cash flow$286.8M-16.6%

Valuation

See full
Market cap$8.96B-33.6%
Enterprise value$8.26B-37.2%
P/E21×-12.0×
P/S3.4×-2.0×

Profitability

See full
Gross margin32.8%+1.4pp
Operating margin20.1%-0.9pp
Net margin16.3%-0.5pp
FCF margin26%-7.8pp

Returns & leverage

See full
Return on equity9.5%—

Where this comes from

Reported directly by Houlihan Lokey in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: Houlihan Lokey’s 10-K, filed May 22, 2026.

Filed
May 22, 2026, 4:43 PM EDT
Fiscal year
FY2026
Accession
0001302215-26-000053
Line itemYear Ended March 31, 2026Year Ended March 31, 2025Year Ended March 31, 2024
Employee compensation and benefits by segment (1)
Corporate Finance965,291871,313638,072
Financial Restructuring299,614289,979282,431
Financial and Valuation Advisory188,526175,412155,502
Non-compensation expense by segment
Corporate Finance198,103181,020166,221
Financial Restructuring49,94845,19345,437
Financial and Valuation Advisory62,11954,18755,670

Item 8. Financial Statements and Supplementary Data

FAQ

What is Houlihan Lokey's financial and valuation advisory — employee compensation and benefits?
Houlihan Lokey (HLI) reported financial and valuation advisory — employee compensation and benefits of $47.13M in Q1 2026.
How has Houlihan Lokey's financial and valuation advisory — employee compensation and benefits changed year-over-year?
Houlihan Lokey's financial and valuation advisory — employee compensation and benefits increased by 7.5% year-over-year, from $43.85M to $47.13M.
What is the long-term trend for Houlihan Lokey's financial and valuation advisory — employee compensation and benefits?
Over 2 years (2024 to 2026), Houlihan Lokey's financial and valuation advisory — employee compensation and benefits has grown at a 10.1% compound annual growth rate (CAGR), from $155.5M to $188.53M.
What does financial and valuation advisory — employee compensation and benefits mean?
The total cost of salaries, bonuses, and benefits paid to personnel dedicated to the Financial and Valuation Advisory segment. As a human-capital-intensive business, this represents the primary operating expense for the segment.

Ask your AI about Houlihan Lokey's financial and valuation advisory — employee compensation and benefits.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude